HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monoclonal antibodies to human laminin α4 chain globular domain inhibit tumor cell adhesion and migration on laminins 411 and 421, and binding of α6β1 integrin and MCAM to α4-laminins.

Abstract
α4-Laminins, such as laminins 411 and 421, are mesenchymal laminins expressed by vascular and lymphatic endothelial cells, leukocytes and other normal cell types. These laminins are recognized by α6β1 and α6β4 integrins and MCAM (CD146), and promote adhesion and migration of the cells. α4-Laminins are also expressed and secreted by some tumor cells and strongly promote tumor cell migration. Moreover, the abluminal side of blood and/or lymphatic vessels and the nerve perineurium, common tracks of tumor cell dissemination, express α4-laminins, and these laminin isoforms, when expressed in the stroma, may contribute to tumor invasion. In the present study, we examined ten mAbs to human laminin α4 chain for their reactivity with the isolated laminin α4 globular domain, their ability to inhibit tumor cell adhesion and migration on laminins 411 and 421, and their effect on the binding of α6β1 integrin and MCAM to both α4-laminins. Most of the mAbs reacted with the laminin α4 globular domain, but only two, mAbs FC10 and 084, significantly inhibited tumor cell adhesion and migration on laminin-411. When used in combination, these antibodies practically abolished the cell adhesion and migration on laminin-411 and significantly reduced the cellular responses on laminin-421. Accordingly, mAbs FC10 and 084 significantly inhibited the binding of purified α6β1 integrin and MCAM to laminins 411 and 421. These results indicate that mAbs to the laminin α4 globular domain are able to inhibit tumor cell adhesion and migration on laminins 411 and 421, and that α6β1 integrin and MCAM bind α4-laminins at very close sites on the globular domain. These reagents contribute to a better understanding of the biology of α4-laminins and may have a therapeutic potential in malignant and inflammatory diseases.
AuthorsTaichi Ishikawa, Zenebech Wondimu, Yuko Oikawa, Sulev Ingerpuu, Ismo Virtanen, Manuel Patarroyo
JournalMatrix biology : journal of the International Society for Matrix Biology (Matrix Biol) Vol. 36 Pg. 5-14 (Jun 2014) ISSN: 1569-1802 [Electronic] Netherlands
PMID24681327 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Antibodies, Monoclonal
  • CD146 Antigen
  • Integrin alpha6beta1
  • LAMA4 protein, human
  • Laminin
  • MCAM protein, human
  • laminin 8
  • laminin 9
Topics
  • Antibodies, Monoclonal (administration & dosage)
  • CD146 Antigen (metabolism)
  • Cell Adhesion (genetics)
  • Cell Line, Tumor
  • Cell Movement (genetics)
  • Humans
  • Integrin alpha6beta1 (metabolism)
  • Laminin (immunology, metabolism)
  • Neoplasms (genetics, metabolism, pathology)
  • Protein Structure, Tertiary

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: